|
[1]YOUNIS RH, HAN KL, WEBB T.Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloidderived suppressor cells expansion fromperipheral blood monocytes[J].J Immunother Cancer, 2015, 3 (Suppl 2) :280-281.
|
|
[2]LAIRD A, O'MAHONY FC, NANDA J, et al.Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome[J].PLo S One, 2013, 8 (4) :e60483.
|
|
[3]WANG YC, QI WQ, ZHAO P.Research advances in insulin-like growth factor-1 receptor in pancreatic cancer[J].J Clin Hepatol, 2017, 33 (4) :790-794. (in Chinese) 王悦超, 亓文骞, 赵平.胰岛素样生长因子1受体在胰腺癌治疗中的机制及进展[J].临床肝胆病杂志, 2017, 33 (4) :790-794.
|
|
[4]CHEN W, ZHENG R, BAADE PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2) :115-132.
|
|
[5]GOU SM, WU HS.Developmental history of the extent of lymph node dissection in pancreatic cancer surgery[J].J Clin Hepatol, 2017, 33 (1) :57-60. (in Chinese) 勾善淼, 吴河水.胰腺癌根治术淋巴结清扫范围的发展历程[J].临床肝胆病杂志, 2017, 33 (1) :57-60.
|
|
[6]YOUNIS RH, HAN KL, WEBB TJ.Human head and neck squamous cell carcinoma-associated Semaphorin 4D induces expansion of myeloid-derived suppressor cells[J].J Immunol, 2016, 196 (3) :1419-1429.
|
|
[7]CH'NG ES, KUMANOGOH A.Roles of Sema4D and Plexin-B1 in tumor progression[J].Mol Cancer, 2010, 21 (9) :251.
|
|
[8]KATO S, KUBOTA K, SHIMAMURA T, et al.Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexin B1, in pancreatic cancer[J].Cancer Sci, 2011, 102 (11) :2029-2037.
|
|
[9]BASILE JR, HOLMBECK K, BUGGE TH, et al.MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D[J].J Biol Chem, 2007, 282 (9) :6899-6905.
|
|
[10]SOONG J, CHEN Y, SHUSTEF EM, et al.Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth[J].J Invest Dermatol, 2012, 132 (4) :1230-1238.
|
|
[11]TURKEL KUCUKMETIN N, CICEK B, SARUC M, et al.Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumors[J].Eur J Gastroenterol Hepatol, 2015, 27 (11) :1276-1280.
|
|
[12]DRAGOMIR LP, SIMIONESCU C, MARGARITESCU C, et al.P53, P16 and Ki67 immunoexpression in oral squamous carcinomas[J].Rom J Morphol Embryol, 2012, 53 (1) :89-93.
|
|
[13]ROSSI L, LAAS E, MALLON P, et al.Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma[J].Br J Cancer, 2015, 113 (7) :996-1002.
|
|
[14]BEUSCHLEIN F, WEIGEL J, SAEGER W, et al.Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection[J].J Clin Endocrinol Metab, 2015, 100 (3) :841.
|
|
[15]LIU M, LAWSON G, DELOS M, et al.Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis:comparison with clinical and radiologic examinations[J].Head Neck, 2003, 25 (4) :280-288.
|
|
[16]YUN F, JIA YF, HAN Z, et al.Expression of HIF-2αin non-small cell lung cancer tissue and its relationship with MRD, Ki67, and GST-π[J].J Jilin Univ:Med Edit, 2016, 42 (5) :954-957. (in Chinese) 云芬, 贾永峰, 韩昭, 等.HIF-2d在非小细胞肺癌组织中的表达及其与微血管密度、Ki67和GST-π的关系[J].吉林大学学报:医学版, 2016, 42 (5) :954-957.
|
|
[17]MU K, WU ZZ, NIU HF, et al.Clinicopathologic characteristics and prognosis of medullary breast carcinoma[J].Chin J Gen Surg, 2017, 32 (3) :211-214. (in Chinese) 穆坤, 吴梓政, 牛海飞, 等.乳腺髓样癌临床病理特征及预后分析[J].中华普通外科杂志, 2017, 32 (3) :211-214.
|
|
[18]GUO JP, KE QG, YUAN ZN.Correlation analysis between Ki-67and p53 expression in breast cancer tissues and preoperative neoadjuvant chemotherapy[J].Clin J Curr Adv Gen Surg, 2017, 20 (2) :90-92. (in Chinese) 郭金培, 柯其广, 原志男.乳腺癌术前新辅助化疗对p53和Ki-67表达的影响[J].中国现代普通外科进展, 2017, 20 (2) :90-92.
|
DownLoad: